Works by Wu-Chou Su


Results: 120
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, v. 13, p. 1, doi. 10.1177/17588359211018022
    By:
    • Huang, Yen-Hsiang;
    • Hung, Jen-Yu;
    • Ko, How-Wen;
    • Su, Po-Lan;
    • Lai, Chun-Liang;
    • Chang, Huang-Chih;
    • Hsia, Te-Chun;
    • Lin, Sheng-Hao;
    • Wu, Kuan-Li;
    • Yang, Cheng-Ta;
    • Su, Wu-Chou;
    • Chu, Yi-Chun;
    • Wang, Chin-Chou;
    • Liao, Wei-Yu;
    • Lin, Yen-Ting;
    • Lin, Ching-Hsiung;
    • Lin, Meng-Chih;
    • Hsu, Kuo-Hsuan;
    • Tseng, Jeng-Sen;
    • Yang, Tsung-Ying
    Publication type:
    Article
    10

    The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211018022
    By:
    • Huang, Yen-Hsiang;
    • Hung, Jen-Yu;
    • Ko, How-Wen;
    • Su, Po-Lan;
    • Lai, Chun-Liang;
    • Chang, Huang-Chih;
    • Hsia, Te-Chun;
    • Lin, Sheng-Hao;
    • Wu, Kuan-Li;
    • Yang, Cheng-Ta;
    • Su, Wu-Chou;
    • Chu, Yi-Chun;
    • Wang, Chin-Chou;
    • Liao, Wei-Yu;
    • Lin, Yen-Ting;
    • Lin, Ching-Hsiung;
    • Lin, Meng-Chih;
    • Hsu, Kuo-Hsuan;
    • Tseng, Jeng-Sen;
    • Yang, Tsung-Ying
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.

    Published in:
    Targeted Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1007/s11523-021-00859-6
    By:
    • Tu, Hai-Yan;
    • Feng, Jifeng;
    • Shi, Meiqi;
    • Zhao, Jun;
    • Wang, Yuyan;
    • Chang, Jianhua;
    • Wang, Jialei;
    • Cheng, Ying;
    • Zhu, Jing;
    • Tan, Eng-Huat;
    • Li, Kai;
    • Zhang, Yiping;
    • Lee, Victor;
    • Yang, Cheng-Ta;
    • Su, Wu-Chou;
    • Lam, David Chi-Leung;
    • Srinivasa, B. J.;
    • Rajappa, Senthil;
    • Ho, Ching-Liang;
    • Lam, Kwok Chi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50